相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Different bone remodeling levels of trabecular and cortical bone in response to changes in Wnt/β-catenin signaling in mice
Junfeng Li et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2017)
Novel splice mutation in LRP4 causes severe type of Cenani-Lenz syndactyly syndrome with oro-facial and skeletal symptoms
Muhammad Afzal et al.
EUROPEAN JOURNAL OF MEDICAL GENETICS (2017)
Serum sclerostin values are associated with abdominal aortic calcification and predict cardiovascular events in patients with chronic kidney disease stages 3-5D
Xue-Rong Wang et al.
NEPHROLOGY (2017)
Sclerostin deficiency in humans
Antoon H. van Lierop et al.
BONE (2017)
Effects of sclerostin antibodies in animal models of osteoporosis
Michael Stuart Ominsky et al.
BONE (2017)
The Optimal Duration of PTH(1-34) Infusion Is One Hour per Day to Increase Bone Mass in Rats
Masaru Shimizu et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2016)
Sclerostin as a new key factor in vascular calcification in chronic kidney disease stages 3 and 4
Wei Lv et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2016)
Sclerostin, cardiovascular disease and mortality: a systematic review and meta-analysis
Mehmet Kanbay et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2016)
A Novel Domain-Specific Mutation in a Sclerosteosis Patient Suggests a Role of LRP4 as an Anchor for Sclerostin in Human Bone
Igor Fijalkowski et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
Only minor differences in renal osteodystrophy features between wild-type and sclerostin knockout mice with chronic kidney disease
Daniel Cejka et al.
KIDNEY INTERNATIONAL (2016)
Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease
Natalia Carrillo-Lopez et al.
KIDNEY INTERNATIONAL (2016)
Changing bone patterns with progression of chronic kidney disease
Tilman B. Drueeke et al.
KIDNEY INTERNATIONAL (2016)
Sclerostin antibody (Scl-Ab) improves osteomalacia phenotype in dentin matrix protein 1(Dmp1) knockout mice with little impact on serum levels of phosphorus and FGF23
Yinshi Ren et al.
MATRIX BIOLOGY (2016)
High Serum Sclerostin Levels Are Associated with a Better Outcome in Haemodialysis Patients
Guillaume Jean et al.
NEPHRON (2016)
Impact of Gap Junctional Intercellular Communication on MLO-Y4 Sclerostin and Soluble Factor Expression
S. L. York et al.
ANNALS OF BIOMEDICAL ENGINEERING (2016)
Effects of dietary iron intake and chronic kidney disease on fibroblast growth factor 23 metabolism in wild-type and hepcidin knockout mice
Mark R. Hanudel et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2016)
Anti-DKK1 antibody promotes bone fracture healing through activation of β-catenin signaling
Hongting Jin et al.
BONE (2015)
Systemic administration of sclerostin monoclonal antibody accelerates fracture healing in the femoral osteotomy model of young rats
Gao Feng et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
Anti-Sclerostin Antibody Treatment in a Rat Model of Progressive Renal Osteodystrophy
Sharon M. Moe et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
Sclerostin Serum Levels and Vascular Calcification Progression in Prevalent Renal Transplant Recipients
P. Evenepoel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Peritoneal dialysis per se is a risk factor for sclerostin-associated adynamic bone disease
Rodrigo A. de Oliveira et al.
KIDNEY INTERNATIONAL (2015)
Increased circulating sclerostin levels in end-stage renal disease predict biopsy-verified vascular medial calcification and coronary artery calcification
Abdul Rashid Qureshi et al.
KIDNEY INTERNATIONAL (2015)
1α,25-dihydroxyvitamin D3 stimulates human SOST gene expression and sclerostin secretion
Asiri R. Wijenayaka et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
Factors associated with serum soluble inhibitors of Wnt--catenin signaling (sclerostin and dickkopf-1) in patients undergoing peritoneal dialysis
Shunsuke Yamada et al.
NEPHROLOGY (2015)
Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcifications
Marion Morena et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Serum sclerostin: the missing link in the bone-vessel cross-talk in hemodialysis patients?
S. Pelletier et al.
OSTEOPOROSIS INTERNATIONAL (2015)
Lrp4 in osteoblasts suppresses bone formation and promotes osteoclastogenesis and bone resorption
Lei Xiong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Osteocytes mediate the anabolic actions of canonical Wnt/β-catenin signaling in bone
Xiaolin Tu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Serum sclerostin is decreased following vitamin D treatment in young vitamin D-deficient female adults
Muharrem Cidem et al.
RHEUMATOLOGY INTERNATIONAL (2015)
Vascular calcification: Mechanisms of vascular smooth muscle cell calcification
Jane A. Leopold
TRENDS IN CARDIOVASCULAR MEDICINE (2015)
Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength of Intact Bones in Adult Male Rats
Pui Kit Suen et al.
SCIENTIFIC REPORTS (2015)
Negative-feedback regulation of the Wnt pathway by conductin/axin2 involves insensitivity to upstream signalling
Dominic B. Bernkopf et al.
JOURNAL OF CELL SCIENCE (2015)
High levels of circulating sclerostin are associated with better cardiovascular survival in incident dialysis patients: results from the NECOSAD study
Christiane Drechsler et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
LRP4 induces extracellular matrix productions and facilitates chondrocyte differentiation
Nobuyuki Asai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
New insights into the location and form of sclerostin
Paula Hernandez et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Bone Mineral Density and Serum Biochemical Predictors of Bone Loss in Patients with CKD on Dialysis
Hartmut H. Malluche et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Effect of supplemental vitamin D and calcium on serum sclerostin levels
Bess Dawson-Hughes et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
Novel SOST gene mutation in a sclerosteosis patient from Morocco: A case report
Mohamed Reda Belkhribchia et al.
EUROPEAN JOURNAL OF MEDICAL GENETICS (2014)
Serum Levels of Sclerostin and Dickkopf-1: Effects of Age, Gender and Fracture Status
Peter Dovjak et al.
GERONTOLOGY (2014)
Osteomalacia induced by vitamin D deficiency in hemodialysis patients: the crucial role of vitamin D correction
Fabrice Mac-Way et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2014)
Relationship Between Serum Sclerostin, Bone Metabolism Markers, and Bone Mineral Density in Maintenance Hemodialysis Patients
Eiji Ishimura et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Serum Sclerostin and Adverse Outcomes in Nondialyzed Chronic Kidney Disease Patients
Mehmet Kanbay et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Renal Elimination of Sclerostin Increases With Declining Kidney Function
Daniel Cejka et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
CKD-Induced Wingless/Integration1 Inhibitors and Phosphorus Cause the CKD-Mineral and Bone Disorder
Yifu Fang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Clinical and Biological Determinants of Sclerostin Plasma Concentration in Hemodialysis Patients
Pierre Delanaye et al.
NEPHRON CLINICAL PRACTICE (2014)
Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levels
Ming-Kang Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Serum sclerostin is an independent predictor of mortality in hemodialysis patients
Flavia Leticia Carvalho Goncalves et al.
BMC NEPHROLOGY (2014)
Sclerostin and DKK1 in Primary Hyperparathyroidism
Ombretta Viapiana et al.
CALCIFIED TISSUE INTERNATIONAL (2013)
The Relation between Renal Function and Serum Sclerostin in Adult Patients with CKD
Solenne Pelletier et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
The Osteocyte: An Endocrine Cell . . . and More
Sarah L. Dallas et al.
ENDOCRINE REVIEWS (2013)
Rapid cortical bone loss in patients with chronic kidney disease
Thomas L. Nickolas et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Disruption of LRP6 in Osteoblasts Blunts the Bone Anabolic Activity of PTH
Changjun Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Sclerostin: Another Vascular Calcification Inhibitor?
Kathleen J. Claes et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Sclerostin: another bone-related protein related to all-cause mortality in haemodialysis?
Liesbeth Viaene et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Disturbances of Wnt/β-catenin pathway and energy metabolism in early CKD: effect of phosphate binders
Rodrigo B. de Oliveira et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Lrp5 and Lrp6 Exert Overlapping Functions in Osteoblasts during Postnatal Bone Acquisition
Ryan C. Riddle et al.
PLOS ONE (2013)
Effects of Dietary Phosphate on Adynamic Bone Disease in Rats with Chronic Kidney Disease - Role of Sclerostin?
Juliana C. Ferreira et al.
PLOS ONE (2013)
Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study
Vincent M. Brandenburg et al.
BMC NEPHROLOGY (2013)
The sclerostin-bone protein interactome
Hemamalini Devarajan-Ketha et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Circulating Sclerostin and Dickkopf-1 (DKK1) in Predialysis Chronic Kidney Disease (CKD): Relationship with Bone Density and Arterial Stiffness
S. Thambiah et al.
CALCIFIED TISSUE INTERNATIONAL (2012)
Structural basis of agrin-LRP4-MuSK signaling
Yinong Zong et al.
GENES & DEVELOPMENT (2012)
Pathophysiology of chronic kidney disease-mineral and bone disorder
Fabrice Mac Way et al.
JOINT BONE SPINE (2012)
Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophy
Yves Sabbagh et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality
Victoria Shalhoub et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients
Daniel Cejka et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
REGULATION AND FUNCTION OF THE FGF23/KLOTHO ENDOCRINE PATHWAYS
Aline Martin et al.
PHYSIOLOGICAL REVIEWS (2012)
Decreased serum sclerostin levels in patients with primary hyperparathyroidism: a cross-sectional and a longitudinal study
M. -S. M. Ardawi et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Osteocyte Network; a Negative Regulatory System for Bone Mass Augmented by the Induction of Rankl in Osteoblasts and Sost in Osteocytes at Unloading
Takeshi Moriishi et al.
PLOS ONE (2012)
Current Concepts and Management Strategies in Chronic Kidney Disease-Mineral and Bone Disorder
Veeraish Chauhan et al.
SOUTHERN MEDICAL JOURNAL (2012)
Autoantibodies to Low-Density Lipoprotein Receptor-Related Protein 4 in Myasthenia Gravis
Osamu Higuchi et al.
ANNALS OF NEUROLOGY (2011)
Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo
Yumie Rhee et al.
BONE (2011)
Sclerostin and Dickkopf-1 in Renal Osteodystrophy
Daniel Cejka et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Genetic Ablation of Sfrp4 in Mice Does Not Affect Serum Phosphate Homeostasis
Marta Christov et al.
ENDOCRINOLOGY (2011)
Bone Overgrowth-associated Mutations in the LRP4 Gene Impair Sclerostin Facilitator Function
Olivier Leupin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Inhibition of Sclerostin by Monoclonal Antibody Enhances Bone Healing and Improves Bone Density and Strength of Nonfractured Bones
Michael S. Ominsky et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Sclerostin Is a Locally Acting Regulator of Late-Osteoblast/Preosteocyte Differentiation and Regulates Mineralization Through a MEPE-ASARM-Dependent Mechanism
Gerald J. Atkins et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Relation of Age, Gender, and Bone Mass to Circulating Sclerostin Levels in Women and Men
Ulrike I. Moedder et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Direct and indirect effects of parathyroid hormone on circulating levels of fibroblast growth factor 23 in vivo
Ignacio Lopez et al.
KIDNEY INTERNATIONAL (2011)
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
Tamara Isakova et al.
KIDNEY INTERNATIONAL (2011)
The Appearance and Modulation of Osteocyte Marker Expression during Calcification of Vascular Smooth Muscle Cells
Dongxing Zhu et al.
PLOS ONE (2011)
Dissecting Molecular Differences between Wnt Coreceptors LRP5 and LRP6
Bryan T. MacDonald et al.
PLOS ONE (2011)
Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway
Asiri R. Wijenayaka et al.
PLOS ONE (2011)
Suppression of Wnt Signaling by Dkk1 Attenuates PTH-Mediated Stromal Cell Response and New Bone Formation
Jun Guo et al.
CELL METABOLISM (2010)
First Missense Mutation in the SOST Gene Causing Sclerosteosis by Loss of Sclerostin Function
Elke Piters et al.
HUMAN MUTATION (2010)
Distinct Modes of Inhibition by Sclerostin on Bone Morphogenetic Protein and Wnt Signaling Pathways
Carola Krause et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Wnt Inhibitors Dkk1 and Sost Are Downstream Targets of BMP Signaling Through the Type IA Receptor (BMPRIA) in Osteoblasts
Nobuhiro Kamiya et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
FGF23 or PTH: which comes first in CKD?
Tamara Isakova et al.
KIDNEY INTERNATIONAL (2010)
Osteocyte Wnt/β-Catenin Signaling Is Required for Normal Bone Homeostasis
Ina Kramer et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Renal bone disease
Stuart M. Sprague
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2010)
PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop
Vardit Lavi-Moshayoff et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Wnt modulators, SFRP-1, and SFRP-2 are expressed in osteoblasts and differentially regulate hematopoietic stem cells
Hideaki Nakajima et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Lrp4, a Novel Receptor for Dickkopf 1 and Sclerostin, Is Expressed by Osteoblasts and Regulates Bone Growth and Turnover In Vivo
Hong Y. Choi et al.
PLOS ONE (2009)
FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1
Jyothsna Gattineni et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Functions of RANKL/RANK/OPG in bone modeling and remodeling
Brendan F. Boyce et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2008)
Osteocytes, mechanosensing and Wnt signaling
Lynda F. Bonewald et al.
BONE (2008)
Wnt signaling control of bone cell apoptosis
Peter V. N. Bodine
CELL RESEARCH (2008)
Parathyroid hormone signaling through low-density lipoprotein-related protein 6
Mei Wan et al.
GENES & DEVELOPMENT (2008)
Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength
Xiaodong Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Control of Bone Mass and Remodeling by PTH Receptor Signaling in Osteocytes
Charles A. O'Brien et al.
PLOS ONE (2008)
Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin
Alexander G. Robling et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Roles of Wnt signaling in bone formation and resorption
Yasuhiro Kobayashi et al.
JAPANESE DENTAL SCIENCE REVIEW (2008)
The parathyroid is a target organ for FGF23 in rats
Iddo Z. Ben-Dov et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1α-hydroxylase expression in vitro
Farzana Perwad et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
PTH stimulates bone formation in mice deficient in Lrp5
Urszula T. Iwaniec et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Metabolic bone disease in chronic kidney disease
Kevin J. Martin et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Identification of a doublet missense substitution in the bovine LRP4 gene as a candidate causal mutation for syndactyly in Holstein cattle
A. Duchesne et al.
GENOMICS (2006)
Wnt/β-catenin signaling is a normal physiological response to mechanical loading in bone
John A. Robinson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia
Ji Li et al.
BONE (2006)
The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment
Kimihiko Sawakami et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass
Frederic Morvan et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Mutations in the gene encoding the low-density lipoprotein receptor LRP4 cause abnormal limb development in the mouse
Dominique Simon-Chazottes et al.
GENOMICS (2006)
Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D
Shiguang Liu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Regulation of bone mass by Wnt signaling
V Krishnan et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice
P Clément-Lacroix et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism
T Shimada et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)
Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: A novel mechanism for hormonal control of osteoblastogenesis
T Bellido et al.
ENDOCRINOLOGY (2005)
Phosphorylation of β-catenin by cyclic AMP-dependent protein kinase stabilizes β-catenin through inhibition of its ubiquitination
S Hino et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Effects of parathyroid hormone on Wnt signaling pathway in bone
NH Kulkarni et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2005)
SOST is a target gene for PTH in bone
H Keller et al.
BONE (2005)
Essential role of β-catenin in postnatal bone acquisition
SL Holmen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Vitamin D and phosphate regulate fibroblast growth factor-23 in K-562 cells
M Ito et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation
DA Glass et al.
DEVELOPMENTAL CELL (2005)
Increased bone resorption in HD patients: is it caused by elevated RANKL synthesis?
I Avbersek-Luznik et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Circulating FGF-23 is regulated by 1α,25-dihydroxyvitamin D3 and phosphorus in vivo
H Saito et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Parathyroid hormone as an anabolic skeletal therapy
MR Rubin et al.
DRUGS (2005)
Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist
RL van Bezooijen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
The importance of bone health in end-stage renal disease: out of the frying pan, into the fire?
HH Malluche et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
PTH differentially regulates expression of RANKL and OPG
JC Huang et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Wnt signals across the plasma membrane to activate the β-catenin pathway by forming oligomers containing its receptors, frizzled and LRP
F Cong et al.
DEVELOPMENT (2004)
Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice
D Sitara et al.
MATRIX BIOLOGY (2004)
Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation
KD Häusler et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Wg/Wnt signal can be transmitted through Arrow/LRP5,6 and Axin independently of Zw3/Gsk3β activity
NS Tolwinski et al.
DEVELOPMENTAL CELL (2003)
Osteocyte control of bone formation via sclerostin, a novel BMP antagonist
DG Winkler et al.
EMBO JOURNAL (2003)
Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone
M Coco et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2000)
分享论文
